WTO nations reached a deal making it easier to manufacture and export patented Covid vaccines in developing countries without consent from the patent holder on.wsj.com
@theguardian.com3 years ago
Paste [[item:78787499]] to render this photo inside an other item's description.
AstraZeneca to create dedicated Covid vaccines unit
@abc.net.au4 years ago
Everything you need to know about the Lambda variant, from a virologist
@forbes.com4 years ago
Nasal Spray Of Covid Vaccine May Be Next: Oxford Reportedly To Test AstraZeneca Version
@qz.com4 years ago
AstraZeneca is developing what may be the most widely accessible Covid-19 vaccine
@WSJ3 years ago
WTO nations reached a deal making it easier to manufacture and export patented Covid vaccines in developing countries without consent from the patent holder on.wsj.com
@abc.net.au3 years ago
Generic COVID-19 vaccines could be key to jabbing the world, and Australia is backing a push to make it happen
@abc.net.au4 years ago
Everything you need to know about the Lambda variant, from a virologist
@aljazeera.com4 years ago
Worth a shot? How one-dose COVID jab could help in pandemic fight
@theconversation.com4 years ago
Moderna's COVID vaccine reports 95% efficacy. It means we might have multiple successful vaccines
@theconversation.com3 years ago
We still need a vaccine patent waiver, but not the one on offer at the World Trade Organization meeting
@forbes.com4 years ago
Oral Covid Vaccine Set To Begin Trials In Israel
@forbes.com4 years ago
New Studies Highlight Promising Candidates For Second-Generation Covid-19 Vaccines
@vox.com4 years ago
The UK approved the Oxford/AstraZeneca Covid-19 vaccine. The US might not get it until April.
@forbes.com3 years ago
Need A Covid-19 Test Right Away? No Problem, But It’ll Cost You
@abc.net.au4 years ago
Everything you need to know about the Lambda variant, from a virologist
@reason.com4 years ago
Novavax Vaccine 100% Effective Against Both Moderate and Severe COVID-19
@forbes.com4 years ago
Questions Over Effectiveness Remain As AstraZeneca And Oxford Release Covid-19 Vaccine Trial Data
